Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Research Data Alliance Releases Guidelines for COVID-19 Data Sharing
Posted on July 24th, 2020 by Xuanyan Xu in COVID-19
The Research Data Alliance (RDA) has released its final version of the RDA COVID-19 Recommendations and Guidelines on data sharing for COVID-19, which covers four main research areas: clinical data, omics practices, epidemiology and social sciences. The document also touches on issues like community participation, legal and ethical considerations, research software and indigenous data.
(more…)The Dawn of a European Health Data Space – Opportunities
Posted on July 9th, 2020 by Mark Siebert in Pharma R&D
At the beginning of 2020, the European Commission introduced a “European strategy for data.” The document proposes to bolster and advance the data economy in Europe with a view towards capturing “the benefits of better use of data, including greater productivity and competitive markets, but also improvements in health and well-being, environment, transparent governance and convenient public services.”
(more…)5 Ways RWE is Fueling the Fight Against COVID-19
Posted on June 19th, 2020 by Xuanyan Xu in COVID-19
As we discussed in an earlier blog post, real-world evidence can bring value to every stage of the drug life cycle, from early discovery to post-market. Now, as the worldwide research community continues to battle the COVID-19 pandemic, we are also discovering how real-world data and real-world evidence have something to offer in these efforts as well.
(more…)The FAIR Toolkit Helps Researchers with Data Challenges
Posted on June 16th, 2020 by Ted Slater in Pharma R&D
Since the spread of COVID-19 was first reported, researchers of all types have mobilized to meet the challenges its causative agent, SARS-CoV-2, presents to the world. Data scientists in particular have been quick to apply their expertise to the problems of identifying, tracking and predicting outbreaks; diagnosing COVID-19; identifying infected individuals and detecting non-compliance with virus countermeasures; discovering new therapeutic interventions or repurposing existing ones; and searching for a safe, effective vaccine.
(more…)
